Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion

Daniela Marotto1, Marta Moschetti2, Alessia Lo Curto2

  • 1Rheumatology Unit, ASL Gallura, 07026 Olbia, Italy.

Insights

Late-onset Pompe disease (LOPD) can present with normal creatinine kinase (CK) levels, mimicking other neuromuscular disorders. Early diagnosis requires enzyme and genetic testing for effective treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Pompe disease (PD), or acid maltase deficiency, is a rare genetic disorder.
  • It results from a deficiency in the lysosomal enzyme acid α-glucosidase, leading to glycogen buildup.
  • This accumulation causes progressive muscle weakness, particularly affecting skeletal muscles and the nervous system in late-onset PD (LOPD).

Observation:

  • This case study details a patient with LOPD who presented with normal creatinine kinase (CK) levels.
  • The patient was initially misdiagnosed with demyelinating motor polyneuropathy and chronic inflammatory neuropathy.
  • Symptoms initially suggested fibromyalgia, leading to a rheumatology consultation.

Findings:

  • Pompe disease was diagnosed via an α-glucosidase assay on dried blood spots (DBS).
  • Enzyme activity was pathologically low, and genetic analysis revealed the c.-32-13T>G mutation in homozygosis.
  • Despite normal CK levels, the patient exhibited characteristic LOPD symptoms.

Implications:

  • This case highlights the diagnostic challenges of LOPD, especially with normal CK values.
  • It underscores the importance of considering PD in patients with nonspecific neuromuscular symptoms.
  • Further research is needed to fully understand the diverse clinical spectrum of Pompe disease.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
914
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
37
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12